All News

The 2024 National Impact Assessment of CMS Quality Measures Report found that adherence to medications for cholesterol, hypertension and diabetes helped Medicare beneficiaries avoid up to $29.2 billion dollars in health care costs from 2016-21.

Two posters presented at ENDO 2024 assessed semaglutide’s impact on taste sensitivity and tirzepatide’s role in body weight reduction.

Clinical recommendations for the management of type 1 diabetes (T1D) in older adults are urgently needed as the global population ages and as improved diabetes care and management of complications have extended the life expectancy of the patient population.

In an attempt to promote flu vaccination, Kristen Thorson, PharmD, encourages pharmacists to “know the power of their recommendation.”

Nicolette Mathey, PharmD, founder of ATRIUM24 and Dotti CRM, discussed how new technological tools can help pharmacists care for more patients.

The world’s information is at our fingertips, but understanding that information and applying it to patient care still requires a rigorous education.

In case you missed it, this week we had news about e-cigarette task forces, combination COVID-19–flu vaccines, updating education on LGBT pain management, and more.

Check out this recap of articles published on our sister sites during the past week.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Patrick Alonso, PharmD, CPh, provides some tips for men looking to improve their overall mental health.

Although a recent study revealed shortcomings associated with ChatGPT and its guidance on medication use, it doesn’t rule out its potential as a valuable health care tool.

Academic, corporate, and clinical institutions must empower pharmacists to deliver informed and compassionate care to LGBTQ individuals that matches the standard received by their heterosexual and cisgender peers.

In abstracts presented at the 2024 American Society of Clinical Oncology’s annual meeting, researchers addressed the association between heart failure and multiple types of cancers.

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

The therapy from AstraZeneca is indicated to improve glycemic control in patients aged 10 years or older.

The Supreme Court ruled on the question of limiting access to to mifepristone, a key abortion drug that anti-abortion groups have been working to limit across the country.

The APhA urged policy makers to consider these recommendations to avoid further exacerbating effects of the attack on US health systems.

Patrick Alonso, PharmD, CPh, discusses how pharmacists can support men dealing with mental health issues and lifestyle changes he recommends to male patients to improve overall health.

In a world rich with diversity, pharmacists need to understand how varied backgrounds and special needs can impact a patient’s decisions in managing their health and medication protocols.

Three posters presented at ENDO 2024 focused on women’s health.

Patients with advanced cancer can experience malignant wounds, which can have a negative impact on quality of life.

Patrick Alonso, PharmD, CPh, owner and manager of BlueZone Health Care Advocates and co-host of the Men’s Health Unscripted podcast, talks about how health care providers can build trust with male patients and what screenings men at different ages should be having.

CDC researchers reported on the improvements and inaccuracies of assays within the Vitamin D Standardization-Certification Program.

As the opioid crisis and injection drug use continue, pharmacists can look to previous outbreaks to guide their responses to the HIV–injection drug use syndemic.

The Lingo and Libre Rio from Abbott are based on the company’s FreeStyle Libre sensing technology.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses how some of the concern’s raised by the panel can inform future psychedelic research.

The new task force highlights a stronger government focus on curbing the risks of e-cigarettes for young people, especially after sustained calls for stricter action on the public health issue by lawmakers and the public.

In a study presented at ASCO 2024, investigators found that all 20 included patients with early stage breast cancer receiving chemotherapy developed hyperglycemia.